We are live on
!
Find out more
HC
Henshaw Capital Portfolio holdings
AUM
$3.07B
Turnover
11.76%
1-Year Est. Return
40.85%
This Fund
S&P 500
This Quarter
Est. Return
+5.32%
1 Year Est. Return
+40.85%
3 Year Est. Return
+128.2%
5 Year Est. Return
+170.36%
10 Year Est. Return
+567.65%
AUM
$977M
AUM Growth
+$21.3M
(+2.2%)
Cap. Flow
-$22.1M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
33.97%
Holding
324
New
40
Increased
71
Reduced
47
Closed
54
Avg Time Held
0.9
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aflac
AFL
|
+$6.76M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$4.98M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$4.3M |
| 4 |
JPMorgan Chase
JPM
|
+$3.24M |
| 5 |
Occidental Petroleum
OXY
|
+$3.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$11.8M |
| 2 |
HCA Healthcare
HCA
|
+$9.33M |
| 3 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$8.94M |
| 4 |
SLB Ltd
SLB
|
+$7.72M |
| 5 |
Hess
HES
|
+$4.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18.55% |
| 2 | Technology | 16.96% |
| 3 | Communication Services | 13.04% |
| 4 | Financials | 12.25% |
| 5 | Healthcare | 10.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Markel Group
MKL
$22.8B
| $2.61M | 0.27% |
2,442
| – | – |
2016 Q1
6 quarters
|
|
52
Vanguard Dividend Appreciation ETF
VIG
$113B
| $2.56M | 0.26% |
26,988
| – | – |
2016 Q4
3 quarters
|
|
53
Teleflex
TFX
$5.49B
| $2.43M | 0.25% |
10,029
-1,434
| -13% | -$312K |
2016 Q1
6 quarters
|
|
54
DELISTED
Ansys
ANSS
| $2.07M | 0.21% |
16,894
| – | – |
2016 Q1
6 quarters
|
|
55
State Street Energy Select Sector SPDR ETF
XLE
$43.5B
| $2.05M | 0.21% |
60,000
| – | – |
2016 Q1
6 quarters
|
|
56
JB Hunt Transport Services
JBHT
$21.4B
| $2.03M | 0.21% |
18,293
| – | – |
2016 Q1
6 quarters
|
|
57
SEI Investments
SEIC
$12.6B
| $2.02M | 0.21% |
33,047
| – | – |
2016 Q1
6 quarters
|
|
58
TransUnion
TRU
$14.1B
| $1.89M | 0.19% |
39,980
+8,753
| +28% | +$400K |
2016 Q3
4 quarters
|
|
59
Bio-Rad Laboratories Class A
BIO
$9.5B
| $1.75M | 0.18% |
7,870
| – | – |
2016 Q1
6 quarters
|
|
60
Aramark
ARMK
$14.7B
| $1.74M | 0.18% |
59,432
+18,034
| +44% | +$523K |
2016 Q1
6 quarters
|
|
61
Affiliated Managers Group
AMG
$9.97B
| $1.68M | 0.17% |
8,841
| – | – |
2016 Q1
6 quarters
|
|
62
Blackbaud
BLKB
$2.33B
| $1.67M | 0.17% |
19,024
| – | – |
2016 Q1
6 quarters
|
|
63
CDW
CDW
$19B
| $1.62M | 0.17% |
24,568
| – | – |
2016 Q1
6 quarters
|
|
64
Fair Isaac
FICO
$16.4B
| $1.57M | 0.16% |
11,139
| – | – |
2016 Q1
6 quarters
|
|
65
TSMC
TSM
$2.15T
| $1.56M | 0.16% |
41,575
+5,143
| +14% | +$188K |
2016 Q1
6 quarters
|
|
66
Manhattan Associates
MANH
$13.1B
| $1.56M | 0.16% |
37,489
+10,528
| +39% | +$461K |
2016 Q1
6 quarters
|
|
67
Carlisle Companies
CSL
$13.3B
| $1.52M | 0.16% |
15,187
| – | – |
2016 Q1
6 quarters
|
|
68
Baidu
BIDU
$27.6B
| $1.48M | 0.15% |
5,993
+89
| +2% | +$19.4K |
2016 Q1
6 quarters
|
|
69
IDEX
IEX
$17.5B
| $1.46M | 0.15% |
12,031
-2,849
| -19% | -$333K |
2016 Q1
6 quarters
|
|
70
Jack Henry & Associates
JKHY
$10.6B
| $1.44M | 0.15% |
14,001
+42
| +0.3% | +$4.35K |
2016 Q1
6 quarters
|
|
71
Kirby Corp
KEX
$7.16B
| $1.41M | 0.14% |
21,440
+5,265
| +33% | +$334K |
2016 Q1
6 quarters
|
|
72
W.R. Berkley
WRB
$27.5B
| $1.41M | 0.14% |
71,115
+26,457
| +59% | +$530K |
2016 Q1
6 quarters
|
|
73
WEX
WEX
$6.18B
| $1.4M | 0.14% |
12,517
| – | – |
2016 Q1
6 quarters
|
|
74
Dentsply Sirona
XRAY
$1.72B
| $1.35M | 0.14% |
22,629
| – | – |
2016 Q1
6 quarters
|
|
75
Morningstar
MORN
$7.76B
| $1.29M | 0.13% |
15,189
| – | – |
2016 Q1
6 quarters
|
|
Similar funds
Henshaw Capital's Q3 2017 Portfolio in Review
As of Q3 2017, Henshaw Capital held 324 positions worth $977M, up 2.2% from $955M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Henshaw Capital's Q3 2017 filing shows 40 new, 71 increased, 47 reduced and 54 closed positions. Its largest new stake was Philip Morris: 7,362 shares worth $817K. The largest sale was Express Scripts Holding Company, an estimated $11.8M.
By sector, the portfolio is most concentrated in Industrials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Communication Services.
- Henshaw Capital's largest Q3 2017 buy was Philip Morris: 7,362 shares worth $817K.
- Henshaw Capital added most to Aflac in Q3 2017, an estimated $6.76M increase.
- Henshaw Capital's biggest Q3 2017 reduction was HCA Healthcare, cutting an estimated $9.33M.
- Henshaw Capital fully exited Express Scripts Holding Company in Q3 2017, selling an estimated $11.8M.
- Henshaw Capital's ten largest holdings make up 34% of its $977M portfolio in Q3 2017.
- Henshaw Capital opened 40 new positions and closed 54 in Q3 2017.
- Henshaw Capital's portfolio value rose 2.2% quarter-over-quarter to $977M.
Based on Henshaw Capital's 13F filing for Q3 2017, filed 28 May 2026.